Mendus announces request for conversion of convertible bonds

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds... | March 28, 2023

Related Keywords

Sweden , Swedish , Erik Manting , Corey Davis , Mario Brkulj , Valency Communications , Swedish Companies Registration Office , Negma Group , Lifesci Advisors , Sci Advisors , Mendus Ab Publ Stock Exchange , News , Information , Press Release , Mendus , Tb , Iopharmaceutical , Company , Ocused , N , Mmunotherapies , Ddressing , Humor , Oday , Nnounced , Hat , Negma , Group , Gas , Y , Notice , O , Equested , The , Conversion , F , Onvertible Immu Se0005003654 ,